January 30, 2024

ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) announces the upcoming launch of JCO Oncology Advances (JCO OA), a new open-access and interdisciplinary journal. We are excited to name Pamela Kunz, MD, as the new Editor-in-Chief of this innovative journal dedicated to accelerating progress in the global fight against cancer by providing a platform where innovation in cancer research meets accessibility.  

January 23, 2024

ALEXANDRIA, Va. — A new study published in the Journal of Clinical Oncology, conducted as part of the St. Jude Lifetime Cohort (SJLIFE), provides new insights into how diet affects aging in adult survivors of childhood cancer. This study, involving 3,322 participants between the ages of 18 and 65, found that higher consumption of dark green vegetables and nuts/seeds is associated with a lower risk of premature aging, while an increased intake of refined grains is linked to a higher risk. These findings, derived from assessments using the Deficit Accumulation Index (DAI), contribute to the growing understanding of the impact of specific dietary choices on the long-term health of childhood cancer survivors. This study is pivotal in understanding the importance of specific plant-based dietary choices in managing long-term health outcomes and enhancing the quality of life for childhood cancer survivors. 

May 19, 2023

ALEXANDRIA, Va. – Jeremy Lyle Warner, MD, MS, FAMIA, FASCO, has been appointed as the next Editor-in-Chief of JCO Clinical Cancer Informatics (JCO CCI), an American Society of Clinical Oncology (ASCO) journal. JCO CCI is an online-only interdisciplinary journal with a primary focus on how information systems help us learn from and improve cancer care, how they interact with each other, and how they serve to advance the field of cancer medicine. 

January 11, 2023

Cancer research sites demonstrated the utility of new resources designed to increase the diversity of participants in cancer clinical trials, although challenges remain, according to two studies published today in JCO Oncology Practice.

November 8, 2022

In the largest study to date of chimeric antigen receptor (CAR) T-cell therapy for relapsed and refractory childhood B-cell acute lymphoblastic leukemia (B-ALL), clinicians in China were able to rapidly produce dual CD19/CD22 targeted T-cells, resulting in treatments that led to undetectable disease in 99% of 194 patients with treatment-resistant or high-risk-of-relapse leukemia, according to a study published today in the Journal of Clinical Oncology. 

October 26, 2022

The American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) today released a joint policy statement outlining the latest research on the use of e-cigarettes and other electronic nicotine delivery systems (ENDS) and recommendations for regulating these products to protect public health. The statement was published in the AACR’s journal Clinical Cancer Research and ASCO’s Journal of Clinical Oncology.

May 19, 2022

The American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC) today jointly released recommendations that address the lack of equity, diversity, and inclusion (EDI) in cancer clinical trials. Published in the Journal of Clinical Oncology, “Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement” details specific actions to engage the entire cancer clinical trial ecosystem in expanding the participation of underrepresented individuals in research that advances progress against cancer.

May 11, 2022

Today, JCO Oncology Practice, a journal of the American Society of Clinical Oncology (ASCO), published a special series that examines the causes of disparities in cancer care and outcomes in the U.S. Hispanic/Latinx population and offers potential solutions to increase equity among this group. "Disparities in Cancer Care and Scientific Knowledge in Hispanic/Latinx People in the United States” features 18 articles and editorials that present new data and opportunities on a wide variety of topics, including prevention and screening, genetic testing, clinical trial enrollment and participation, access to affordable health care, and workforce representation, among others. 

 

February 22, 2022

ALEXANDRIA, Va. – Jeffrey Peppercorn, MD, MPH, has been appointed as the next Editor-in-Chief of JCO Oncology Practice (JCO OP), an American Society of Clinical Oncology (ASCO) journal. JCO OP publishes impactful information and insights to keep oncology practice current on changes and challenges inherent in delivering equitable, high-quality oncology care with an evolving value-based lens.

 

July 13, 2021

The American Society of Clinical Oncology (ASCO) and the Community Oncology Alliance (COA) jointly released new Oncology Medical Home (OMH) standards, which provide a comprehensive roadmap for oncology practices to deliver high-quality, evidence-based cancer care.

May 11, 2021

A new special series in JCO Oncology Practice, a journal of the American Society of Clinical Oncology (ASCO), explores the causes of disparities in cancer care and outcomes for Black people in the United States and examines potential solutions to begin to achieve health equity for this population.

January 25, 2021

Survivors of adolescent and young adult cancers may be at increased risk of experiencing adverse mental health outcomes, with patients treated at adult cancer centers at higher risk than those treated at pediatric cancer centers, according to a study published today in the Journal of Clinical Oncology. 

October 16, 2020

Oncology providers familiar with the ASCO guideline on older adults with cancer are two to four times more likely to conduct a geriatric assessment on patients with cancer over the age of 65, according to the first international ASCO survey aimed at determining if and how often cancer providers are using geriatric assessments when treating older adults.

May 15, 2019

A new study published today in the Journal of Oncology Practice (JOP) reveals the findings of a 2018 American Society of Clinical Oncology (ASCO) Oncology Workforce survey on oncologists’ perceptions and practice behaviors related to diet, physical activity, and weight management in people with cancer — during and after active treatment. The research was also presented today at the American Institute for Cancer Research (AICR) 2019 Research Conference, Diet, Obesity, Physical Activity and Cancer  Beyond the Blueprint.

March 29, 2018

Linda D. Bosserman, MD, FACP, FASCO, has been named Editor-in-Chief of the Journal of Oncology Practice (JOP), a publication of the American Society of Clinical Oncology (ASCO). Dr. Bosserman is a recognized leader in cancer care delivery with a deep understanding of the issues impacting all types of oncology practices.